title: Central locomotor and cognitive effects of a NPFF receptor agonist in mouse.
abstract: NPFF receptors are expressed in several brain regions directly or indirectly involved in cognition and behavior. However, the cognitive effects of the NPFF system have been poorly studied. Therefore, the aim of our study was to analyze the effects of i.c.v. injections of 1 DMe, a stable agonist of NPFF receptors, on behavioral and cognitive performances in C57BL/6J mice. We measured locomotor activity, and an open field with objects was used to estimate the ability of mice to react to spatial changes and to measure short-term retention of information. The Morris navigation task was used to evaluate the acquisition, as well as long-term retention of a hippocampo-dependent spatial memory with a distributed training procedure. Finally, 1 DMe was tested in a contextual fear conditioning paradigm to study its effect on long-term memory of contextual information acquired in a single training session. Altogether, our results demonstrate a small but complex influence of the NPFF system on mouse behavior. 1 DMe injected i.c.v. induces a delayed hyperlocomotion and mildly impairs both short-term and long-term spatial memory processing without affecting contextual fear memory.
authors.affiliation: Université de Toulouse, Centre de Recherches sur la Cognition Animale, France.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Betourne
authors.forename: Virginie
authors.initials: V
authors.lastname: Marty
authors.forename: Johnatan
authors.initials: J
authors.lastname: Ceccom
authors.forename: Hélène
authors.initials: H
authors.lastname: Halley
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Lassalle
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Zajac
authors.forename: Bernard
authors.initials: B
authors.lastname: Frances
authors.forename: Lionel
authors.initials: L
authors.lastname: Mouledous
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000494:pharmacology; D003071:Cognition / Q000187:drug effects*; D003213:Conditioning, Psychological / Q000187:drug effects; D046352:Freezing Reaction, Cataleptic / Q000187:drug effects; D007276:Injections, Intraventricular; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D008570:Memory, Short-Term / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects*; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D018013:Receptors, Neuropeptide / Q000819:agonists* / Q000378:metabolism
chemical_list: D002491:Central Nervous System Agents; D009842:Oligopeptides; D018013:Receptors, Neuropeptide; C083929:neuropeptide FF receptor; C105455:neuropeptide FF, Tyr(1)-N-methyl-Phe(3)-